Results 241 to 250 of about 496,699 (309)

Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial. [PDF]

EClinicalMedicine
Kadife E, Decloedt E, Louw V, Abdulla ZB, Kellermann T, Pillay-Fuentes Lorente V, Cluver C, Middleton A, Kaitu'u-Lino TJ, Said JM, Tong S, Brownfoot FC.   +11 more
europepmc   +1 more source

Correction: How is Levetiracetam Monotherapy Currently Monitored in Pregnancy? A Systematic Review. [PDF]

Clin Pharmacokinet
Rademaker T, Goo Y, Soh MC, Pasupathy D, Wong C, Bleasel A, Alffenaar JW.   +6 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of desoxycorticosterone pivalate in dogs with hypoadrenocorticism. [PDF]

J Vet Intern Med
Langlois DK, Dirikolu L, Brudvig JM, Lehner AF, Nelms LL, Carey SA, Jablonski SA, Cridge H, Bassiouny E, Zyskowski J, Buchweitz JP.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pharmacokinetics

Biochemical Pharmacology, 2014
Pharmacokinetics (PK) is the study of the time course of the absorption, distribution, metabolism and excretion (ADME) of a drug, compound or new chemical entity (NCE) after its administration to the body. Following a brief introduction as to why knowledge of the PK properties of an NCE is critical to its selection as a lead candidate in a drug ...
Jianghong, Fan, Inés A M, de Lannoy
openaire   +2 more sources

Lumping in Pharmacokinetics

Journal of Pharmacokinetics and Pharmacodynamics, 2005
Pharmacokinetic (PK) models simplify biological complexity by dividing the body into interconnected compartments. The time course of the chemical's amount (or concentration) in each compartment is then expressed as a system of ordinary differential equations.
Brochot, Céline, Toth, Janos, Bois, Frédéric Y.   +2 more
openaire   +4 more sources